搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
The Pharma Letter
1 小时
MeiraGTx rises on positive study of AAV-GAD for Parkinson’s disease
US clinical-stage genetic meds company MeiraGTx Holdings has released positive top-line data from its clinical bridging study ...
The Pharma Letter
2 小时
J&J reports strong third quarter with 5.2% revenue boost
Johnson & Johnson (NYSE: JNJ) has reported revenue of $22.5 billion for the third quarter of 2024, a 5.2% increase ...
The Pharma Letter
2 小时
Novartis halts Phase II study of LTP001 in idiopathic pulmonary fibrosis
Novartis halted its Phase II IPF trial for LTP001, citing non-safety reasons. This move aligns with its strategy to ...
The Pharma Letter
3 小时
Akeso raises $250 million to fuel global development
Akeso Biopharma (HKEX: 9926) raised $250M via share placement, boosting cash reserves to over $1B. Funds will fast-track ...
The Pharma Letter
3 小时
Mirikizumab bests ustekinumab in Phase III Crohn's disease study
US pharma major Eli Lilly has released new data demonstrating more patients with moderately to severely active Crohn's ...
The Pharma Letter
3 小时
Lilly plans $206 million boost to Chinese manufacturing
Eli Lilly (NYSE: LLY) plans to invest $206M to expand its Suzhou, China site for Type 2 diabetes and obesity drugs. The ...
The Pharma Letter
4 小时
Almirall’s efinaconazole a step closer to European patients
Almirall has completed the decentralized EU regulatory procedure for efinaconazole (Jublia) for onychomycosis. The final step ...
The Pharma Letter
4 小时
Inventiva announces financing of up to 348 million euros
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 ...
The Pharma Letter
5 小时
Celltrion presents 2-year post-hoc analysis findings for subcutaneous infliximab
South Korea-based biosimilar drug developer Celltrion today announced two-year results of subcutaneous infliximab (CT-P13 SC) ...
The Pharma Letter
5 小时
How ADCs are changing the treatment of cancer
Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...
The Pharma Letter
5 小时
Sernova announces batch of appointments
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. This strategic ...
The Pharma Letter
6 小时
BRIEF—Germany becomes first country to launch LEO Pharma’s Anzupgo
Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈